Beeline Medicines
PrivateLast Round
Series A
Jun 30, 2026
Total Funding Raised
$1.15B
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Beeline Medicines is a biotechnology company that develops precision therapies for autoimmune and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beeline Medicines Comparables
Compare Beeline Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Santa Ana Bio | 88% | |
| Cugene Inc. | 79% | |
| Ventus Therapeutics | 78% |
Beeline Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 30, 2026 | ||||
| Series A | Apr 15, 2026 | ||||
| Series A | Jul 1, 2025 |
Key People
Founding team and executive leadership
Beeline Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CPP Investments | Series A |
| Bain Capital, LP | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2026
$126M round with participation from Bain Capital and CPP Investments.
- Apr 15, 2026
$300M round raised.
Beeline Medicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Beeline Medicines's valuation, stock price, and market status.
Is Beeline Medicines a public or private company?
Beeline Medicines is a private company.
What is the current stock price of Beeline Medicines?
Beeline Medicines is a private company with no public stock price. No recent secondary market data is available.
How much is Beeline Medicines worth (valuation)?
Valuation information for Beeline Medicines is not publicly available.
Can I buy Beeline Medicines stock?
Beeline Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Beeline Medicines's last funding round?
Beeline Medicines's most recent funding round was Series A Extension on June 30, 2026.
Who are the main investors in Beeline Medicines?
Key investors in Beeline Medicines include Bain Capital, LP.
Will Beeline Medicines IPO soon?
No public IPO plans have been announced for Beeline Medicines.
How can I track Beeline Medicines secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Beeline Medicines's secondary market activity and sign up for updates.